83 related articles for article (PubMed ID: 7245516)
1. Correlation of higher prevalence of pancreatic disease with excess parathyroid hormone in uremia.
Avram MM
Trans Am Soc Artif Intern Organs; 1980; 26():372-4. PubMed ID: 7245516
[No Abstract] [Full Text] [Related]
2. Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients.
Schaefer K; Offermann G; von Herrath D; Schröter R; Stölzel R; Arntz HR
Clin Nephrol; 1980 Aug; 14(2):81-8. PubMed ID: 7408260
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic disease in uremia and parathyroid hormone excess.
Avram RM; Iancu M
Nephron; 1982; 32(1):60-2. PubMed ID: 7177279
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone is not an inhibitor of lipoprotein lipase activity.
Arnadottir M; Nilsson-Ehle P
Nephrol Dial Transplant; 1994; 9(11):1586-9. PubMed ID: 7870347
[TBL] [Abstract][Full Text] [Related]
5. [Kidney damage in acute pancreatic diseases].
Dabels J; Diwok K; Gülzow M
Dtsch Z Verdau Stoffwechselkr; 1967 Mar; 26(5):229-41. PubMed ID: 5595723
[No Abstract] [Full Text] [Related]
6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
7. [Parathyroid hormone, a simple hormone or uremic toxin?].
Massy ZA; Drueke TB; Romet M
Nephrol Ther; 2011 Feb; 7(1 Suppl 1):H1-4. PubMed ID: 21511201
[No Abstract] [Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
9. [The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration].
Civati G; Guastoni C; Perego A; Galato R; Brando B; Grillo C; Surian M; Colussi G; Teatini U; Minetti L
Minerva Nefrol; 1981; 28(2):171-4. PubMed ID: 7290521
[No Abstract] [Full Text] [Related]
10. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
[TBL] [Abstract][Full Text] [Related]
11. Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.
Kazama JJ; Omori T; Ei I; Ei K; Oda M; Maruyama H; Narita I; Gejyo F; Shigematsu T; Fukagawa M
Clin Exp Nephrol; 2003 Jun; 7(2):144-9. PubMed ID: 14586733
[TBL] [Abstract][Full Text] [Related]
12. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
[TBL] [Abstract][Full Text] [Related]
13. [Role of hypertension in determining valvular diseases in patients with chronic uremia and dialytic treatment].
Facchin L; Nordio M; Levedianos G; Dilanas C; Marchini P; Leprotti C; Vescovo G
Cardiologia; 1998 Dec; 43(12):1361-6. PubMed ID: 9988945
[TBL] [Abstract][Full Text] [Related]
14. [Variations of parathyroid hormone and hypophyseal hormones in patients in periodic hemodialytic treatment].
Giusti M; Gurreri G; Motta A; Mazzocchi G; Mortara R
Minerva Nefrol; 1980; 27(3):513-21. PubMed ID: 7231801
[No Abstract] [Full Text] [Related]
15. Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease.
Monier-Faugere MC; Mawad H; Malluche HH
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1255-60. PubMed ID: 17942766
[TBL] [Abstract][Full Text] [Related]
16. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of adynamic bone disease in uremia.
Fournier A; Said S; Ghazali A; Sechet A; Ezaitouni F; Marie A; Westeel PF; Morinière P; Boudailliez B
Adv Nephrol Necker Hosp; 1997; 27():131-66. PubMed ID: 9408446
[No Abstract] [Full Text] [Related]
18. Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis.
Palermo A; Mulè G; Guarneri M; Arsena R; Riccobene R; Lorito MC; Vaccaro F; Cerasola G; Cottone S
Nephrology (Carlton); 2008 Dec; 13(6):467-71. PubMed ID: 18518931
[TBL] [Abstract][Full Text] [Related]
19. Hyperparathyroidism: is it really the major factor affecting glucose tolerance in uremia?
Bergesio F; Bandini S; Cresci B; Monzani G; Rotella C; Conti A; Rosati A; Piperno R; Messeri G; Frizzi V; Salvadori M
Miner Electrolyte Metab; 1996; 22(1-3):187-91. PubMed ID: 8676816
[TBL] [Abstract][Full Text] [Related]
20. Does hyperparathyroidism cause pancreatitis? A South Indian experience and a review of published work.
Jacob JJ; John M; Thomas N; Chacko A; Cherian R; Selvan B; Nair A; Seshadri M
ANZ J Surg; 2006 Aug; 76(8):740-4. PubMed ID: 16916398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
